GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atrion Corp (NAS:ATRI) » Definitions » Beneish M-Score
中文

Atrion (Atrion) Beneish M-Score : -2.39 (As of Apr. 25, 2024)


View and export this data going back to 1972. Start your Free Trial

What is Atrion Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.39 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Atrion's Beneish M-Score or its related term are showing as below:

ATRI' s Beneish M-Score Range Over the Past 10 Years
Min: -2.94   Med: -2.5   Max: -2.23
Current: -2.39

During the past 13 years, the highest Beneish M-Score of Atrion was -2.23. The lowest was -2.94. And the median was -2.50.


Atrion Beneish M-Score Historical Data

The historical data trend for Atrion's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrion Beneish M-Score Chart

Atrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.40 -2.68 -2.52 -2.48 -2.39

Atrion Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.48 -2.62 -2.45 -2.21 -2.39

Competitive Comparison of Atrion's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Atrion's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrion's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atrion's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Atrion's Beneish M-Score falls into.



Atrion Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Atrion for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.042+0.528 * 1.1226+0.404 * 0.975+0.892 * 0.9227+0.115 * 0.934
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1685+4.679 * 0.00102-0.327 * 0.7078
=-2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $23.0 Mil.
Revenue was 43.584 + 41.911 + 43.838 + 39.993 = $169.3 Mil.
Gross Profit was 16.317 + 13.736 + 17.254 + 15.081 = $62.4 Mil.
Total Current Assets was $114.8 Mil.
Total Assets was $260.8 Mil.
Property, Plant and Equipment(Net PPE) was $125.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $15.1 Mil.
Selling, General, & Admin. Expense(SGA) was $33.1 Mil.
Total Current Liabilities was $12.6 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.
Net Income was 6.424 + 2.939 + 6.563 + 3.485 = $19.4 Mil.
Non Operating Income was 0.505 + -0.782 + 0.127 + -0.711 = $-0.9 Mil.
Cash Flow from Operations was 10.858 + 5.418 + -0.598 + 4.328 = $20.0 Mil.
Total Receivables was $24.0 Mil.
Revenue was 42.855 + 44.631 + 48.882 + 47.138 = $183.5 Mil.
Gross Profit was 18.174 + 17.653 + 20.833 + 19.244 = $75.9 Mil.
Total Current Assets was $119.4 Mil.
Total Assets was $264.7 Mil.
Property, Plant and Equipment(Net PPE) was $123.8 Mil.
Depreciation, Depletion and Amortization(DDA) was $13.8 Mil.
Selling, General, & Admin. Expense(SGA) was $30.7 Mil.
Total Current Liabilities was $18.1 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23.029 / 169.326) / (23.951 / 183.506)
=0.136004 / 0.130519
=1.042

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(75.904 / 183.506) / (62.388 / 169.326)
=0.413632 / 0.368449
=1.1226

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (114.765 + 125.347) / 260.825) / (1 - (119.397 + 123.754) / 264.712)
=0.079413 / 0.081451
=0.975

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=169.326 / 183.506
=0.9227

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.812 / (13.812 + 123.754)) / (15.098 / (15.098 + 125.347))
=0.100403 / 0.107501
=0.934

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(33.118 / 169.326) / (30.716 / 183.506)
=0.195587 / 0.167384
=1.1685

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 12.621) / 260.825) / ((0 + 18.098) / 264.712)
=0.048389 / 0.068369
=0.7078

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(19.411 - -0.861 - 20.006) / 260.825
=0.00102

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Atrion has a M-score of -2.39 suggests that the company is unlikely to be a manipulator.


Atrion (Atrion) Business Description

Traded in Other Exchanges
N/A
Address
One Allentown Parkway, Allen, TX, USA, 75002-4211
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Executives
Preston G Athey director ONE ALLENTOWN PKWY, ALLEN TX 75002
David A Battat officer: President & CEO 2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103
Jeannette Bankes director ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Morgan Hugh J Jr director
Ronald Nicholas Spaulding director ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Cindy Ferguson officer: Officer/ CFO ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffery Strickland officer: Vice President & CFO
Emile A Battat director, officer: Chairman ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Stupp John P Jr director STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124
Roger F Stebbing director
Ronald N Spaulding director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Richard O Jacobson director ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002
Maley John H P director 6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377
Margaret Maxwell Zagel director C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532

Atrion (Atrion) Headlines

From GuruFocus

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-09-2022

Atrion Reports Second Quarter 2022 Results

By PurpleRose PurpleRose 08-08-2022

Atrion Corporation Declares Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 06-13-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 06-18-2022

Atrion Corporation Announces Election of New Director

By Marketwired Marketwired 08-30-2021

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 06-08-2022

Atrion Reports First Quarter 2023 Results

By sperokesalga sperokesalga 05-08-2023

Atrion Corporation Declares Quarterly Cash Dividend

By PurpleRose PurpleRose 07-14-2022